Loading...

GUTS FRACTYL HEALTH INC Product Launches 8-K Filing

FRCT

GTS

FRACTYL HEALTH INC

(GUTS)

2024 8-K

Summary

Summary

Stockholder Meeting

Stock Offering Announcement

Interim Study Results

Equity Offerings

Product Expansion

Post-Market Surveillance

Clinical Trials

Product Expansion

Financial Statements

Positive Study Data

Annual Meeting Notice

Financial Results

Clinical Study Update

New Therapy Candidate

External Links:

Fractyl Health, Inc. announced its first pancreatic gene therapy candidate, RJVA-002, for obesity treatment and will present new preclinical data at The Obesity Society's Annual Meeting on November 5, 2024.

AI Assistant

FRACTYL HEALTH INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.